Ginkgo Bioworks Holdings (DNA) FCF Margin (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly FCF Margin of 248.36% for Q1 2026, down 9366.0% year-on-year from 2.68% in Q1 2025, and down 73.95% on a QoQ basis from 142.78% in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of FCF Margin data on file, last reported at 248.36% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 9366.0% year-over-year to 248.36%; the trailing twelve-month figure through Mar 2026 stood at 118.85% (up 3305.0% YoY), and the FY2025 full-year result was 105.04%, up 6327.0% from the prior year.
- FCF Margin for Q1 2026 stood at 248.36%, down from 142.78% in the prior quarter.
- Across five years, FCF Margin topped out at 13.94% in Q1 2022 and bottomed at 252.92% in Q1 2024.
- The 5-year median for FCF Margin is 136.34% (2023), against an average of 132.87%.
- The widest annual swing landed in 2022, when FCF Margin soared 14495 bps; it then plunged 12239 bps in 2023.
- A 5-year view of FCF Margin shows it stood at 149.36% in 2022, then decreased by 18 bps to 176.31% in 2023, then increased by 27 bps to 128.05% in 2024, then dropped by 12 bps to 142.78% in 2025, then plunged by 74 bps to 248.36% in 2026.
- The last three FCF Margin figures came in at 248.36% (Q1 2026), 142.78% (Q4 2025), and 81.38% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -248.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -248.36% |
| Dec 31, 2025 | -142.78% |
| Sep 30, 2025 | -81.38% |
| Jun 30, 2025 | -81.23% |
| Mar 31, 2025 | -154.70% |
| Dec 31, 2024 | -128.05% |
| Sep 30, 2024 | -133.18% |
| Jun 30, 2024 | -198.24% |
| Mar 31, 2024 | -252.92% |
| Dec 31, 2023 | -176.31% |
| Sep 30, 2023 | -140.60% |
| Jun 30, 2023 | -108.07% |
| Mar 31, 2023 | -136.34% |
| Dec 31, 2022 | -149.36% |
| Sep 30, 2022 | -37.96% |
| Jun 30, 2022 | -75.36% |
| Mar 31, 2022 | -13.94% |
| Dec 31, 2021 | -114.92% |
| Sep 30, 2021 | -13.75% |
| Jun 30, 2021 | -135.08% |
| Mar 31, 2021 | -158.89% |
| Dec 31, 2020 | -245.65% |